Classical Macrophage Activation Up-Regulates Several Matrix Metalloproteinases through Mitogen Activated Protein Kinases and Nuclear Factor-κB
暂无分享,去创建一个
Wei-Chun Huang | Angela Susana | Jason L. Johnson | Andrew C. Newby | Wei-Chun Huang | A. Newby | G. Sala-Newby | Graciela B. Sala-Newby | A. Susana | Angela Susana
[1] A. Newby. Metalloproteinase Expression in Monocytes and Macrophages and its Relationship to Atherosclerotic Plaque Instability , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[2] C. Brinckerhoff,et al. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors , 2001, Arthritis Research & Therapy.
[3] L. Lue,et al. Gene expression changes by amyloid β peptide‐stimulated human postmortem brain microglia identify activation of multiple inflammatory processes , 2006, Journal of leukocyte biology.
[4] Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. , 2004, The Journal of clinical investigation.
[5] S. Chakraborti,et al. Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.
[6] K. Schroder,et al. Interferon- : an overview of signals, mechanisms and functions , 2004 .
[7] D. Edwards,et al. The regulation of matrix metalloproteinases and their inhibitors. , 2008, The international journal of biochemistry & cell biology.
[8] M. Duddy,et al. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. , 2003, Brain : a journal of neurology.
[9] D. Mazzatti,et al. Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium , 2009, Pflügers Archiv - European Journal of Physiology.
[10] S. Gordon,et al. Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.
[11] J. Friedland,et al. Matrix metalloproteinases in tuberculosis , 2011, European Respiratory Journal.
[12] Gillian Murphy,et al. Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.
[13] D. Ramji,et al. Critical Role for Casein Kinase 2 and Phosphoinositide-3-Kinase in the Interferon-&ggr;–Induced Expression of Monocyte Chemoattractant Protein-1 and Other Key Genes Implicated in Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[14] Peter Libby,et al. Atherosclerosis and proteinase activation. , 2006, Cardiovascular research.
[15] A. Newby,et al. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. , 2005, Physiological reviews.
[16] Markus S. Mueller,et al. MMP19 Is Essential for T Cell Development and T Cell-Mediated Cutaneous Immune Responses , 2008, PloS one.
[17] William C. Parks,et al. Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.
[18] P. Libby,et al. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. , 2006, Journal of the American College of Cardiology.
[19] Alberto Mantovani,et al. Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.
[20] D. Pei. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage , 1999, Cell Research.
[21] C. Kaps,et al. Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study , 2008, Arthritis research & therapy.
[22] A. Mantovani,et al. Analysis of the Gene Expression Profile Activated by the CC Chemokine Ligand 5/RANTES and by Lipopolysaccharide in Human Monocytes1 , 2002, The Journal of Immunology.
[23] J. Foidart,et al. Matrix metalloproteinase-19 deficiency promotes tenascin-C accumulation and allergen-induced airway inflammation. , 2010, American journal of respiratory cell and molecular biology.
[24] Silvano Sozzani,et al. Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.
[25] A. Baker,et al. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. , 1999, Biochemical and biophysical research communications.
[26] A. Newby,et al. Role of Nuclear Factor-&kgr;B Activation in Metalloproteinase-1, -3, and -9 Secretion by Human Macrophages In Vitro and Rabbit Foam Cells Produced In Vivo , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[27] W. English,et al. Matrix metalloproteinases in arthritic disease , 2002, Arthritis research.
[28] P. Libby,et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.
[29] Wei-Chun Huang,et al. Diverse patterns of cyclooxygenase-independent metalloproteinase gene regulation in human monocytes , 2011, British journal of pharmacology.
[30] Jeffrey W. Smith,et al. Inflammatory Proprotein Convertase-Matrix Metalloproteinase Proteolytic Pathway in Antigen-presenting Cells as a Step to Autoimmune Multiple Sclerosis* , 2009, The Journal of Biological Chemistry.
[31] D. Pei,et al. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. , 2004, Experimental Cell Research.
[32] L. Boscá,et al. Cot/tpl2 activity is required for TLR‐induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression , 2011, European journal of immunology.
[33] A. Newby,et al. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. , 2001, Cardiovascular research.
[34] Andrew J. Ewald,et al. Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.
[35] Anne M Manicone,et al. Matrix metalloproteinases as modulators of inflammation. , 2008, Seminars in cell & developmental biology.
[36] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[37] K. Schroder,et al. Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.
[38] R. Sedláček,et al. Matrix Metalloproteinase-19 Is Expressed in Myeloid Cells in an Adhesion-Dependent Manner and Associates with the Cell Surface1 , 2002, The Journal of Immunology.
[39] Jason L Johnson,et al. Low Tissue Inhibitor of Metalloproteinases 3 and High Matrix Metalloproteinase 14 Levels Defines a Subpopulation of Highly Invasive Foam-Cell Macrophages , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[40] W. English,et al. Membrane-type 1-Matrix Metalloproteinase Regulates Intracellular Adhesion Molecule-1 (ICAM-1)-mediated Monocyte Transmigration* , 2007, Journal of Biological Chemistry.
[41] T. Salo,et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation , 2006, Annals of medicine.